Jean and other ER+/PR-
The following will be presented at ASCO on 6/4/06
"
ER+ PR- breast cancer defines a unique subtype of breast cancer that is driven by growth factor signaling and may be more likely to respond to EGFR targeted therapies.
Abstract No: 514"
Rhonda
|